DRUG · Unmapped registry intervention
SB-509
Find medicine records ·
Find other trials using this name
Clinical trial
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
NCT00406458
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Normal Saline
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedClinical Trial of SB-509 in Subjects With Diabetic Neuropathy
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
SB-509DRUG
Normal SalineOTHER
Sponsors & collaborators
Sangamo Therapeuticslead sponsor
Juvenile Diabetes Research Foundationcollaborator
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1MiamiFlorida, United States1San AntonioTexas, United States1San FranciscoCalifornia, United States1OmahaNebraska, United States1La JollaCalifornia, United States1Kansas CityKansas, United States1AlbanyNew York, United States1Walnut CreekCalifornia, United States1BradentonFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00406458 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.